Gut microbiota and ovarian diseases: a new therapeutic perspective

被引：0

作者：

Shan Ju ^{[1
]}

Zhen Yang Kang ^{[2
]}

Li Ya Yang ^{[3
]}

Yong Jun Xia ^{[3
]}

Yi Ming Guo ^{[1
]}

Sui Li ^{[2
]}

Hongli Yan ^{[3
]}

Ming Kang Qi ^{[1
]}

Hui Ping Wang ^{[4
]}

Lian Zhong ^{[2
]}

机构：

[1] University of Shanghai for Science and Technology,School of Health Science and Engineering, Shanghai Engineering Research Center of Food Microbiology

[2] Chinese Academy of Medical Sciences,Graduate School of Peking Union Medical College

[3] National Research Institute for Family Planning,NHC Key Laboratory of Reproductive Health Engineering Technology Research (NRIFP)

[4] Changhai hospital,undefined

[5] the Navy medical university,undefined

来源：

Journal of Ovarian Research | / 18卷 / 1期

关键词：

Gut microbiota; Premature ovarian insufficiency; Polycystic ovary syndrome; Ovarian tumors;

D O I：

10.1186/s13048-025-01684-5

中图分类号：

学科分类号：

摘要：

The gut microbiota is a complex community of microorganisms that inhabit the human gastrointestinal tract, helping to maintain the ecological balance of the body’s internal and external environments. Disruptions in the composition and diversity of gut microbiota, as well as changes in their metabolic functions, can link to the development and severity of conditions such as premature ovarian insufficiency, polycystic ovary syndrome, and ovarian tumors. This article thoroughly reviews recent research on the connection between gut microbiota and ovarian diseases, providing fresh perspectives on their prevention, pathogenesis, and treatment.

引用

共 50 条

[21] The gut microbiota in retinal diseases
Bringer, Marie-Agnes
Gabrielle, Pierre-Henry
Bron, Alain M.
Creuzot-Garcher, Catherine
Acar, Niyazi
EXPERIMENTAL EYE RESEARCH, 2022, 214
[22] Gut Microbiota, Leaky Gut, and Autoimmune Diseases
Christovich, Anna
Luo, Xin M.
FRONTIERS IN IMMUNOLOGY, 2022, 13
[23] Pathogenic or Therapeutic: The Mediating Role of Gut Microbiota in Non-Communicable Diseases
Bu, Fan
Yao, Xingran
Lu, Zhihua
Yuan, Xiaomin
Chen, Chen
Li, Lu
Li, Youran
Jiang, Feng
Zhu, Lei
Shi, Guoping
Chen, Yugen
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
[24] An update on the role of gut microbiota in chronic inflammatory diseases, and potential therapeutic targets
Laing, Bobbi
Barnett, Matthew P. G.
Marlow, Gareth
Nasef, Noha Ahmed
Ferguson, Lynnette R.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (10) : 969 - 983
[25] Intestinal Immunity and Gut Microbiota as Therapeutic Targets for Preventing Atherosclerotic Cardiovascular Diseases
Yamashita, Tomoya
Kasahara, Kazuyuki
Emoto, Takuo
Matsumoto, Takuya
Mizoguchi, Taiji
Kitano, Naoki
Sasaki, Naoto
Hirata, Ken-ichi
CIRCULATION JOURNAL, 2015, 79 (09) : 1882 - 1890
[26] Association between premature ovarian insufficiency and gut microbiota
Jiaman Wu
Yuanyuan Zhuo
Yulei Liu
Yan Chen
Yan Ning
Jilong Yao
BMC Pregnancy and Childbirth, 21
[27] Association between premature ovarian insufficiency and gut microbiota
Wu, Jiaman
Zhuo, Yuanyuan
Liu, Yulei
Chen, Yan
Ning, Yan
Yao, Jilong
BMC PREGNANCY AND CHILDBIRTH, 2021, 21 (01)
[28] The synergistic role of gut microbiota and RNA in metabolic diseases: mechanisms and therapeutic insights
Huang, Zhuo
Yao, Qinyan
Ma, Shuang
Zhou, Jinjie
Wang, Xiaoxuan
Meng, Qingguo
Liu, Yaxin
Yu, Zihan
Chen, Xin
FRONTIERS IN MICROBIOLOGY, 2025, 16
[29] New perspective on fecal microbiota transplantation in liver diseases
Suk, Ki Tae
Koh, Hong
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (01) : 24 - 33
[30] The gut microbiota: a new perspective on the toxicity of malachite green (MG)
Li, Tongtong
Tian, Dongcan
Zhu, Zhenzhen
Jin, Weihua
Wu, Shijin
Li, Huan
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2019, 103 (23-24) : 9723 - 9737

← 1 2 3 4 5 →